Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![BiopharmIQ Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::811036897883492352.png) BiopharmIQ by Amp [@BiopharmIQ](/creator/twitter/BiopharmIQ) on x 25.7K followers
Created: 2025-07-18 22:53:55 UTC

🧬 Biotech Weekly News 7/14/25 - 7/18/25
⭐ Major Movers 📈 📉

$TELO XX% Telomir-1 Update in Prostate Cancer
$KAPA XX% Positive Results from Ph2 Trial
$MEIP XX% $100M Private Placement
$DARE XX% Ovaprene Interim Ph3 Results
$RCKT XX% Receives RMAT Designation for Gene Therapy

$SRPT -XX% FDA Shipment Halt Warning for Elevidys
$CLSD -XX% Explore Strategic Alternatives for SCS Platform
$BCLI -XX% Nasdaq Delisting & OTCQB Transition
$ABOS -XX% Strategic Collab. for Alzheimer's Therapy
$IKNA -X% Stockholder Approval of Merger
See image below. 📸

🚨 $SRPT closed down XX% after reports of 3rd gene therapy–related death!
This time from acute liver failure in a limb-girdle trial.
FDA may halt Elevidys shipments following two prior Duchenne fatalities. 🚫

💡 Days earlier, @BowTiedBiotech warned:
“🧬 History Repeating Itself?: ELEVIDYS Is Starting to Look a Lot Like Glybera?”
Check out post 👇

![](https://pbs.twimg.com/media/GwLMOwBasAANKCN.jpg)

XXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1946342699277418706/c:line.svg)

**Related Topics**
[$bcli](/topic/$bcli)
[$clsd](/topic/$clsd)
[$srpt](/topic/$srpt)
[$rckt](/topic/$rckt)
[$dare](/topic/$dare)
[$100m](/topic/$100m)
[$meip](/topic/$meip)
[$kapa](/topic/$kapa)

[Post Link](https://x.com/BiopharmIQ/status/1946342699277418706)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

BiopharmIQ Avatar BiopharmIQ by Amp @BiopharmIQ on x 25.7K followers Created: 2025-07-18 22:53:55 UTC

🧬 Biotech Weekly News 7/14/25 - 7/18/25 ⭐ Major Movers 📈 📉

$TELO XX% Telomir-1 Update in Prostate Cancer $KAPA XX% Positive Results from Ph2 Trial $MEIP XX% $100M Private Placement $DARE XX% Ovaprene Interim Ph3 Results $RCKT XX% Receives RMAT Designation for Gene Therapy

$SRPT -XX% FDA Shipment Halt Warning for Elevidys $CLSD -XX% Explore Strategic Alternatives for SCS Platform $BCLI -XX% Nasdaq Delisting & OTCQB Transition $ABOS -XX% Strategic Collab. for Alzheimer's Therapy $IKNA -X% Stockholder Approval of Merger See image below. 📸

🚨 $SRPT closed down XX% after reports of 3rd gene therapy–related death! This time from acute liver failure in a limb-girdle trial. FDA may halt Elevidys shipments following two prior Duchenne fatalities. 🚫

💡 Days earlier, @BowTiedBiotech warned: “🧬 History Repeating Itself?: ELEVIDYS Is Starting to Look a Lot Like Glybera?” Check out post 👇

XXXXX engagements

Engagements Line Chart

Related Topics $bcli $clsd $srpt $rckt $dare $100m $meip $kapa

Post Link

post/tweet::1946342699277418706
/post/tweet::1946342699277418706